Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Sitagliptin

Single oral administration of sitagliptin 100 mg

DRUG

Mitiglinide

Single oral administration of mitiglinide 10 mg

DRUG

Sitagliptin, Mitiglinide

Concomitant administration of sitagliptin 100 mg and mitiglinide 10 mg

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

JW Pharmaceutical

INDUSTRY

lead

Samsung Medical Center

OTHER

NCT01422590 - Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin | Biotech Hunter | Biotech Hunter